Skip to Content
Merck
  • Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH.

Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH.

Scientific reports (2020-12-05)
Laurent L'homme, Benan Pelin Sermikli, Olivier Molendi-Coste, Sébastien Fleury, Sandrine Quemener, Mathilde Le Maître, Marie-Laure Joseph, Laurent Pineau, Christian Duhem, Barbara Gross, Emmanuelle Vallez, Anne Tailleux, Bart Staels, David Dombrowicz
ABSTRACT

Retinoic acid receptor-related orphan receptor-alpha (RORα) is a transcription factor from the nuclear receptor family expressed by immune cells and involved in the development of obesity, insulin resistance (IR) and non-alcoholic steatohepatitis (NASH). It was recently reported that mice deficient for RORα in macrophages develop more severe NASH upon high fat diet (HFD) feeding due to altered Kupffer cell function. To better understand the role of RORα in obesity and IR, we independently generated a macrophage RORα-deficient mouse line. We report that RORα deletion in macrophages does not impact on HFD-induced obesity and IR. Surprisingly, we did not confirm an effect on NASH development upon HFD feeding nor in the more severe and obesity-independent choline-deficient, L-amino acid-defined diet model. Our results therefore show that RORα deletion in macrophages does not alter the development of obesity and IR and question its role in NASH.

MATERIALS
Product Number
Brand
Product Description

Ethanol solution, NIST® SRM® 2898a, nominal mass fraction 6%
Sigma-Aldrich
Eosin Y Solution, Alcoholic
Sigma-Aldrich
Harris Hematoxylin Solution, Modified
Sigma-Aldrich
Direct Red 80, Dye content 25 %
Sigma-Aldrich
REDExtract-N-Amp Tissue PCR Kit, sufficient for 10 reactions, sufficient for 100 reactions, sufficient for 1000 reactions, hotstart, dNTPs included
Sigma-Aldrich
Dexamethasone, ≥98% (HPLC), powder